Bernstein Maintains Outperform on Agilon Health, Raises Price Target to $138
Benzinga Newsdesk 14 hours ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Bernstein analyst Lance Wilkes maintains Agilon Health (NYSE:AGL) with a Outperform and raises the price target from $125 to $138.
Bernstein analyst Lance Wilkes maintains Agilon Health (NYSE:AGL) with a Outperform and raises the price target from $125 to $138.
